Extracellular targeted drug conjugates
Abstract:
Extracellular drug conjugates (EDCs) targeting CD38 are useful in the treatment of diseases such as cancer and immune disorders, including asthma.
Public/Granted literature
Information query
Patent Agency Ranking
0/0